UBS Maintains a 'Neutral' on Illumina (ILMN); Drama Takes Backseat, Results Slightly Better Than Expected

April 24, 2012 10:52 AM EDT Send to a Friend
Get Alerts ILMN Hot Sheet
Price: $73.08 +1.50%

Rating Summary:
    11 Buy, 12 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 20 | Down: 41 | New: 13
Trade ILMN Now!
UBS maintains a 'Neutral' on Illumina (NASDAQ: ILMN) price target lowered from $55 to $48.

Analyst, Daniel Arias, said, "Revenues of $273M (-3% y/y, + 9% q/q) were just above pre-announced levels, while gross margins of 69.0% (+80 bps y/y, -120 bps q/q) & op margins of 26.7% yielded EPS of $0.36 vs. Street $0.32. With Roche gone (for now), ILMN’s call was mild, as the Street re-focused on execution...We remain Neutral on shares, as we believe ILMN looks fairly valued against the current market backdrop." (UBS raises FY12 EPS estimate from $1.44 to $1.48 and maintains FY13 at $1.63)

For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.

Shares of Illumina closed at $43.90 yesterday, with a 52 week range of $25.57-$79.40.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS

Add Your Comment